Sankar, SavitaTanner, Jason MBell, RussellChaturvedi, AashiRandall, R LorBeckerle, Mary CLessnick, Stephen L
Oncogenic transformation in Ewing sarcoma is caused by EWS/FLI, an aberrant transcription factor fusion oncogene. Glioma-associated oncogene homolog 1 (GLI1) is a critical target gene activated by EWS/FLI, but the mechanism by which GLI1 contributes to the transformed phenotype of Ewing sarcoma was unknown. In this work, we identify keratin 17 (KRT...
Subbiah, VivekBrown, Robert EJiang, YunyunBuryanek, JamieHayes-Jordan, AndreaKurzrock, RazelleAnderson, Pete M
BackgroundDesmoplastic small round cell tumor (DSRCT) is a rare sarcoma in adolescents and young adults. The hallmark of this disease is a EWS-WT1 translocation resulting from apposition of the Ewing's sarcoma (EWS) gene with the Wilms' tumor (WT1) gene. We performed morphoproteomic profiling of DSRCT (EWS-WT1), Ewing's sarcoma (EWS-FLI1) and Wilms...
Huang, Helen JAngelo, Laura SRodon, JordiSun, MichaelKuenkele, Klaus-PeterParsons, Henrique ATrent, Jonathan CKurzrock, Razelle
A subset of patients with Ewing's sarcoma responds to anti-insulin-like growth factor-1 receptor (IGF-1R) antibodies. Mechanisms of sensitivity and resistance are unknown. We investigated whether an anti-IGF-1R antibody acts via a pathway that could also be suppressed by small interfering (si) RNA against the EWS/FLI-1 fusion protein, the hallmark ...